Trademark: 90891747
Status Date
Wednesday, February 21, 2024
Filing Date
Thursday, August 19, 2021
Published for Opposition
Tuesday, January 3, 2023
42 Research and development for medical cell-based immunotherapies and regenerative medicine; pharmaceutical immunotherapy and regenerative medicine drug development services; Providing information in the fields of regenerative medicine research and immunotherapy research; scientific study and research in the fields of immunotherapy research and regenerative medicine
Feb 22, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 21, 2024
Sou Extension 2 Granted
Feb 21, 2024
Sou Extension 2 Filed
Feb 21, 2024
Sou Teas Extension Received
Aug 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 28, 2023
Sou Extension 1 Granted
Aug 28, 2023
Sou Extension 1 Filed
Aug 28, 2023
Sou Teas Extension Received
Feb 28, 2023
Noa E-Mailed - Sou Required From Applicant
Jan 3, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 3, 2023
Published For Opposition
Dec 14, 2022
Notification Of Notice Of Publication E-Mailed
Nov 26, 2022
Approved For Pub - Principal Register
Nov 23, 2022
Teas/Email Correspondence Entered
Nov 22, 2022
Correspondence Received In Law Office
Nov 22, 2022
Teas Response To Office Action Received
May 31, 2022
Notification Of Non-Final Action E-Mailed
May 31, 2022
Non-Final Action E-Mailed
May 31, 2022
Non-Final Action Written
May 20, 2022
Assigned To Examiner
Oct 7, 2021
New Application Office Supplied Data Entered
Sep 27, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 27, 2021
Teas Change Of Correspondence Received
Sep 27, 2021
Teas Change Of Owner Address Received
Aug 23, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
